Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey L Smith

Showing results (51-60 of 163) with videos related to

Pageof 17
Sort By:
The Journal of General Virology|July 19, 2002
The vaccinia virus N1L protein is an intracellular homodimer that promotes virulenceNathan Bartlett, Julian A Symons, David C Tscharke, et al.
The Journal of General Virology|May 25, 2012
Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virionsVirginie Doceul, Michael Hollinshead, Adrien Breiman, et al.
The Journal of General Virology|April 12, 2001
A mutational analysis of the vaccinia virus B5R proteinElizabeth C Mathew, Christopher M Sanderson, Ruth Hollinshead, et al.
The Journal of General Virology|July 19, 2002
A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulenceJulian A Symons, David C Tscharke, Nicola Price, et al.
Vaccine|August 22, 2016
Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulatorsRebecca P Sumner, Hongwei Ren, Brian J Ferguson, et al.
Frontiers in Microbiology|December 8, 2022
Manipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteinsYongxu Lu, Hendrik A Michel, Pei-Hui Wang, et al.
The Journal of General Virology|August 22, 2001
The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulenceAylwin Ng, David C Tscharke, Patrick C Reading, et al.
Nature Medicine|November 7, 2006
Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccinationMike M Pütz, Claire M Midgley, Mansun Law, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 30, 2010
Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytesDaniel López, Margarita García-Calvo, Geoffrey L Smith, et al.
The Journal of General Virology|July 14, 2012
Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulenceStuart W J Ember, Hongwei Ren, Brian J Ferguson, et al.
Pageof 17

Showing results (51-60 of 163) with videos related to

Sort By:
Pageof 17
The Journal of General Virology|July 19, 2002
The vaccinia virus N1L protein is an intracellular homodimer that promotes virulenceNathan Bartlett, Julian A Symons, David C Tscharke, et al.
The Journal of General Virology|May 25, 2012
Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virionsVirginie Doceul, Michael Hollinshead, Adrien Breiman, et al.
The Journal of General Virology|April 12, 2001
A mutational analysis of the vaccinia virus B5R proteinElizabeth C Mathew, Christopher M Sanderson, Ruth Hollinshead, et al.
The Journal of General Virology|July 19, 2002
A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulenceJulian A Symons, David C Tscharke, Nicola Price, et al.
Vaccine|August 22, 2016
Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulatorsRebecca P Sumner, Hongwei Ren, Brian J Ferguson, et al.
Frontiers in Microbiology|December 8, 2022
Manipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteinsYongxu Lu, Hendrik A Michel, Pei-Hui Wang, et al.
The Journal of General Virology|August 22, 2001
The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulenceAylwin Ng, David C Tscharke, Patrick C Reading, et al.
Nature Medicine|November 7, 2006
Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccinationMike M Pütz, Claire M Midgley, Mansun Law, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 30, 2010
Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytesDaniel López, Margarita García-Calvo, Geoffrey L Smith, et al.
The Journal of General Virology|July 14, 2012
Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulenceStuart W J Ember, Hongwei Ren, Brian J Ferguson, et al.
Pageof 17